Sedation in the intensive care unit with remifentanil/propofol versus midazolam/fentanyl: a randomised, open-label, pharmacoeconomic trial

Table 2 Patient demography and baseline characteristics

	Remifentanil/propofol	Midazolam/fentanyl
Number of patients analysed	39	33
Mean age (years)	65 ± 8.1	66.5 ± 7.0
Male/female	30/9	23/10
Mean height (cm)/weight (kg)	169.9 ± 8.8/80.1 ± 12.7	170.5 ± 7.1/83.9 ± 12.1
ASA physical status (I/II/III)	0/0/39	0/0/33
Type of surgery^a
Bypass surgery	33	31
Valve surgery	11	8
Mean ejection fraction (%) at screening	49.5 ± 12.7	50.3 ± 15.8
Mean SAPS II on admission	37.6 ± 14.2	28.2 ± 11.7

Values are number of patients or mean ± standard deviation. ^aMultiple counts are possible per subject. SAPS, simplified acute physiology score.

ISSN: 1364-8535